循环生物标志物市场预计在 2023 年至 2031 年期间的复合年增长率为 10.1%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。
循环生物标志物市场报告涵盖了按产品(循环 DNA、循环肿瘤细胞、其他)和最终用户(医院、医学研究中心、其他)进行的分析。全球分析进一步细分为区域和主要国家。报告以美元为单位提供了上述分析和细分的价值。
报告目的
The Insight Partners 发布的《循环生物标志物市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:
- 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
- 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
- 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。
循环生物标志物市场细分
产品
- 循环DNA
- 循环肿瘤细胞
- 其他
最终用户
- 医院
- 医学研究中心
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
循环生物标志物市场增长动力
- 非侵入性诊断技术的进步:循环生物标志物市场的增长主要得益于非侵入性诊断技术的进步。这些生物标志物在癌症和慢性病管理中的作用越来越受到认可,从而推动了市场扩张。
- 生物标志物发现的投资:市场趋势显示,生物标志物发现的投资正在激增。竞争分析显示,各公司正致力于提高生物标志物的特异性和检测能力,从而增强其市场竞争力。
- 癌症发病率和早期检测:全球癌症发病率的上升推动了对早期检测解决方案的需求,从而加速了市场增长。生物标记在个性化医疗中发挥着关键作用,可带来更好的治疗效果和更高的存活率。
循环生物标志物市场未来趋势
- 癌症诊断领域的变革:循环生物标志物正在彻底改变癌症诊断领域的液体活检应用。市场的主要参与者正在大力投资开发新的检测平台,以提高检测的准确性和速度,为长期增长做好准备。
- 分析技术的创新:分析技术的最新创新使循环生物标志物的检测更加准确可靠。这些进步通过增强检测能力和确定行业未来增长战略来塑造市场动态。
- 个性化医疗的机遇:SWOT 分析突出了个性化医疗的重大机遇。循环生物标志物在有针对性的治疗干预和精准健康监测中变得至关重要。随着个性化医疗的不断发展,循环生物标志物市场有望实现大幅增长,尤其是随着人们越来越关注个人健康状况和治疗。
循环生物标志物市场机会
- 非侵入性液体活检:液体活检因其非侵入性而受到广泛关注,这使得其在医学诊断中得到更广泛的接受。循环生物标志物检测的简便性和效率正在加速其应用,尤其是在北美和欧洲,那里的肿瘤学创新解决方案机会越来越多。
- 肿瘤学研究和市场扩张:对肿瘤学研究和研究的日益关注推动了对循环生物标志物的需求。专门从事癌症诊断的公司在定义市场格局方面发挥着关键作用。因此,亚太地区对先进癌症诊断解决方案的需求日益增长,因此有很大机会进入尚未开发的市场。
- 合作与战略伙伴关系:循环生物标志物的开发在很大程度上受到与大学和研究机构的战略伙伴关系的影响。这些合作增强了公司的研发能力,并允许地域扩张,尤其是进入新兴地区。这种方法不仅可以提高主要参与者的市场份额,还可以加速创新并加强他们在全球市场的地位。
循环生物标志物市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响循环生物标志物市场的区域趋势和因素。本节还讨论了循环生物标志物市场在北美、欧洲、亚太地区、中东和非洲以及南美和中美的细分市场和地理位置。
- 获取循环生物标志物市场的区域特定数据
循环生物标志物市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | XX 百万美元 |
2031 年市场规模 | XX 百万美元 |
全球复合年增长率(2023 - 2031) | 10.1% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
循环生物标志物市场参与者密度:了解其对业务动态的影响
循环生物标志物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在循环生物标志物市场运营的主要公司有:
- 通用电气医疗
- 安捷伦科技
- 表观基因组学公司
- Fluxion 生物科学
- 艾菲美
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取循环生物标志物市场顶级关键参与者概述
主要卖点
- 全面覆盖:该报告全面涵盖了循环生物标志物市场的产品、服务、类型和最终用户的分析,提供了整体概况。
- 专家分析:报告基于对行业专家和分析师的深入了解而编写。
- 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
- 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。
因此,循环生物标志物市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Circulating Biomarkers Market is estimated to witness a CAGR of 10.1% from 2023 to 2031.
The major factors driving the market are: Shift toward liquid biopsies, Advancements in genomics and proteomics, Increasing cancer prevalence
Key future trends in this market are - Rising Adoption in Liquid Biopsy, Advances in Biomarker Profiling Technologies, Expanding Role in Personalized Medicine
Key companies of this market are: GE Healthcare, Agilent Technologies, Epigenomics AG, Fluxion Biosciences, Affymetrix, BD, Abbott Laboratories, Biocept.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. GE Healthcare
2. Agilent Technologies
3. Epigenomics AG
4. Fluxion Biosciences
5. Affymetrix
6. BD
7. Abbott Laboratories
8. Biocept
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.